Syntegon is expanding its pharmaceutical processing and packaging business with the acquisition of Azbil Telstar. Telstar was previously part of Japan's Azbil Corporation. Telstar, based in Terrassa (Barcelona), Spain, is a manufacturer and supplier of equipment to the global life and health science industry. Telstar is an important addition to Syntegon's liquid pharmaceutical processing portfolio, with approximately 900 employees, manufacturing facilities in Spain, China and the UK, and engineering, sales and service offices around the world. Telstar will also benefit from further growth opportunities as part of the Syntegon Group. Syntegon and Azbil have agreed not to disclose financial details. The transaction remains subject to regulatory approval.
Seamless solutions from a single source
Telstar has a strong, experienced team serving pharmaceutical, life science and medical device customers around the world, particularly in Southern and Western Europe, the USA and India. Freeze dryers and loading/unloading systems, including comprehensive services, are key additions to Syntegon's portfolio and ideally complement its leading vial filling and isolator solutions. With the expanded portfolio, Syntegon will be even better positioned to offer both pharmaceutical manufacturers and CMOs complete one-stop solutions. In addition, the Syntegon service network will be significantly enhanced by the addition of Telstar service engineers, providing additional geographic coverage, proximity and application expertise.
Strategic expansion with innovative technologies
“Syntegon is world market leader in liquid vial filling. With the acquisition of Telstar, we will enhance our portfolio of innovative technologies and many successful references in the market. Our customers will benefit from even more comprehensive solutions, seamless processes, and lifecycle services,” says Torsten Türling, CEO of the Syntegon Group. “At the same time, we can jointly capture growth opportunities and expand our market presence.”
“For Telstar, the incorporation into the Syntegon Group represents a great opportunity to ensure stable business development and future growth. We look forward to bringing our knowledge, expertise, and high-value technologies for aseptic manufacturing to the joint portfolio and to becoming part of the Syntegon team, backed by a shared business culture,” says Jordi Puig, CEO of Telstar.
